These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17620221)

  • 1. Disposition of loratadine in healthy volunteers.
    Ramanathan R; Reyderman L; Kulmatycki K; Su AD; Alvarez N; Chowdhury SK; Alton KB; Wirth MA; Clement RP; Statkevich P; Patrick JE
    Xenobiotica; 2007 Jul; 37(7):753-69. PubMed ID: 17620221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and excretion of loratadine in male and female mice, rats and monkeys.
    Ramanathan R; Alvarez N; Su AD; Chowdhury S; Alton K; Stauber K; Patrick J
    Xenobiotica; 2005 Feb; 35(2):155-89. PubMed ID: 16019945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of desloratadine in healthy volunteers.
    Ramanathan R; Reyderman L; Su AD; Alvarez N; Chowdhury SK; Alton KB; Wirth MA; Clement RP; Statkevich P; Patrick JE
    Xenobiotica; 2007 Jul; 37(7):770-87. PubMed ID: 17620222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Tissue Distribution of Loratadine, Desloratadine and Their Active Metabolites in Rat based on a Newly Developed LC-MS/MS Analytical Method.
    Zhang Y; Lu Y; Wang L; Tian Y; Zhang Z
    Drug Res (Stuttg); 2020 Nov; 70(11):528-540. PubMed ID: 32877950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in high-resolution MS and hepatocyte models solve a long-standing metabolism challenge: the loratadine story.
    Aratyn-Schaus Y; Ramanathan R
    Bioanalysis; 2016 Aug; 8(16):1645-62. PubMed ID: 27460981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of loratadine and its active metabolite in human plasma by high-performance liquid chromatography with mass spectrometry detection.
    Vlase L; Imre S; Muntean D; Leucuta SE
    J Pharm Biomed Anal; 2007 Jul; 44(3):652-7. PubMed ID: 16962733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.
    Noehr-Jensen L; Damkier P; Bidstrup TB; Pedersen RS; Nielsen F; Brosen K
    Eur J Clin Pharmacol; 2006 Jun; 62(6):437-45. PubMed ID: 16770647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans.
    Molimard M; Diquet B; Benedetti MS
    Fundam Clin Pharmacol; 2004 Aug; 18(4):399-411. PubMed ID: 15312146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective, open-label analysis of the population pharmacokinetics of a single 10-mg dose of loratadine in healthy white Jordanian male volunteers.
    Salem II; Najib NM; Idkaidek NM
    Clin Ther; 2010 Feb; 32(2):391-5. PubMed ID: 20206796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of loratadine and its active metabolite descarboethoxyloratadine in healthy Chinese subjects.
    Zhang YF; Chen XY; Zhong DF; Dong YM
    Acta Pharmacol Sin; 2003 Jul; 24(7):715-8. PubMed ID: 12852841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian time-effect of orally administered loratadine on plasma pharmacokinetics in mice.
    Dridi D; Ben-Attia M; Sani M; Djebli N; Sauvage FL; Boughattas NA
    Chronobiol Int; 2008 Jul; 25(4):533-47. PubMed ID: 18622814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on determination of desloratadine in human serum and its pharmacokinetics by HPLC/MS].
    Lu XY; Sheng-Tu JZ; Chen ZG; Huang MZ; Zhou HL; Zheng GG
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 34(4):372-4. PubMed ID: 16059990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyp2d6*10 allele on the pharmacokinetics of loratadine in chinese subjects.
    Yin OQ; Shi XJ; Tomlinson B; Chow MS
    Drug Metab Dispos; 2005 Sep; 33(9):1283-7. PubMed ID: 15932952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution, metabolism, and excretion (ADME) of ¹⁴C-sonidegib (LDE225) in healthy volunteers.
    Zollinger M; Lozac'h F; Hurh E; Emotte C; Bauly H; Swart P
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):63-75. PubMed ID: 24817600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of desloratadine poor metabolizer phenotype in healthy Jordanian males.
    Hakooz N; Salem II
    Biopharm Drug Dispos; 2012 Jan; 33(1):15-21. PubMed ID: 22271705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics/pharmacodynamics of desloratadine and fluoxetine in healthy volunteers.
    Gupta S; Banfield C; Kantesaria B; Flannery B; Herron J
    J Clin Pharmacol; 2004 Nov; 44(11):1252-9. PubMed ID: 15496643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective β(3)-adrenoceptor agonist, after oral administration to healthy male volunteers.
    Takusagawa S; van Lier JJ; Suzuki K; Nagata M; Meijer J; Krauwinkel W; Schaddelee M; Sekiguchi M; Miyashita A; Iwatsubo T; van Gelderen M; Usui T
    Drug Metab Dispos; 2012 Apr; 40(4):815-24. PubMed ID: 22269146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers.
    Polsky-Fisher SL; Vickers S; Cui D; Subramanian R; Arison BH; Agrawal NG; Goel TV; Vessey LK; Murphy MG; Lasseter KC; Simpson RC; Vega JM; Rodrigues AD
    Drug Metab Dispos; 2006 Jun; 34(6):1004-11. PubMed ID: 16510541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects.
    Gerisch M; Hafner FT; Lang D; Radtke M; Diefenbach K; Cleton A; Lettieri J
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):195-206. PubMed ID: 29188322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.